These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 7716719

  • 1. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease.
    Borst MJ, VanCamp JM, Peacock ML, Decker RA.
    Surgery; 1995 Apr; 117(4):386-91. PubMed ID: 7716719
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of MEN 2a in familial Hirschsprung's disease: a new indication for genetic testing of the RET proto-oncogene.
    Decker RA, Peacock ML.
    J Pediatr Surg; 1998 Feb; 33(2):207-14. PubMed ID: 9498388
    [Abstract] [Full Text] [Related]

  • 3. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
    Pasini B, Rossi R, Ambrosio MR, Zatelli MC, Gullo M, Gobbo M, Collini P, Aiello A, Pansini G, Trasforini G, degli Uberti EC.
    Surgery; 2002 Apr; 131(4):373-81. PubMed ID: 11935126
    [Abstract] [Full Text] [Related]

  • 4. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1995 Apr; 79():L-LV. PubMed ID: 8600671
    [Abstract] [Full Text] [Related]

  • 5. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
    Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G, Takahashi M.
    Cancer Res; 1997 Jul 15; 57(14):2870-2. PubMed ID: 9230192
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
    Inoue K, Shimotake T, Inoue K, Tokiwa K, Iwai N.
    J Pediatr Surg; 1999 Oct 15; 34(10):1552-4. PubMed ID: 10549772
    [Abstract] [Full Text] [Related]

  • 7. C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
    Caron P, Attié T, David D, Amiel J, Brousset F, Roger P, Munnich A, Lyonnet S.
    J Clin Endocrinol Metab; 1996 Jul 15; 81(7):2731-3. PubMed ID: 8675603
    [Abstract] [Full Text] [Related]

  • 8. Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A.
    Landsvater RM, Jansen RP, Hofstra RM, Buys CH, Lips CJ, Ploos van Amstel HK.
    Hum Genet; 1996 Jan 15; 97(1):11-4. PubMed ID: 8557249
    [Abstract] [Full Text] [Related]

  • 9. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).
    Oishi S, Sato T, Takiguchi-Shirahama S, Nakamura Y.
    Endocr J; 1995 Aug 15; 42(4):527-36. PubMed ID: 8556060
    [Abstract] [Full Text] [Related]

  • 10. Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis.
    Peacock ML, Borst MJ, Sweet JD, Decker RA.
    Hum Mutat; 1996 Aug 15; 7(2):100-4. PubMed ID: 8829625
    [Abstract] [Full Text] [Related]

  • 11. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C, Desclaux-Arramond F, Raffin-Sanson M, Corvol JC, De Keyzer Y, Luton JP, Plouin PF, Bertagna X.
    J Clin Endocrinol Metab; 1995 Jul 15; 80(7):2063-8. PubMed ID: 7608256
    [Abstract] [Full Text] [Related]

  • 12. Mutations of the RET proto-oncogene in Hirschsprung's disease.
    Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fékété C, Ponder BA, Munnich A.
    Nature; 1994 Jan 27; 367(6461):378-80. PubMed ID: 8114939
    [Abstract] [Full Text] [Related]

  • 13. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain.
    Sánchez B, Robledo M, Biarnes J, Sáez ME, Volpini V, Benítez J, Navarro E, Ruiz A, Antiñolo G, Borrego S.
    J Med Genet; 1999 Jan 27; 36(1):68-70. PubMed ID: 9950371
    [Abstract] [Full Text] [Related]

  • 14. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
    Cancer; 2002 Jan 15; 94(2):323-30. PubMed ID: 11900218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.
    Blaugrund JE, Johns MM, Eby YJ, Ball DW, Baylin SB, Hruban RH, Sidransky D.
    Hum Mol Genet; 1994 Oct 15; 3(10):1895-7. PubMed ID: 7849720
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Frilling A, Dralle H, Eng C, Raue F, Broelsch CE.
    Surgery; 1995 Dec 15; 118(6):1099-103; discussion 1103-4. PubMed ID: 7491529
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.
    Padberg BC, Schröder S, Jochum W, Kastendieck H, Roth J, Heitz PU, Komminoth P.
    Am J Pathol; 1995 Dec 15; 147(6):1600-7. PubMed ID: 7495285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.